On April 28, 2022, the Bureau of Indian Standards (BIS) issued notification announcing market surveillance of products covered under Compulsory Registration Scheme(CRS). Main contents are summarized as follows:
1. As per conditions of license to use Standard Mark under Regulation 6 of BIS (Conformity Assessment) Regulations, 2018, all licensees are required to submit details of their consignees, distributors, dealers or retailers. In case of multiple brands under a single license, the details may please be submitted brand-wise.
2. It is intended to take up the market surveillance activity in phases. Emails/letters are being sent to the concerned licensees for providing the requisite information and depositing the fees with BIS.
3. BIS will charge the cost of samples and testing fee of the sample drawn for surveillance, that is, the licensee shall deposit the surveillance cost for their respective products for the licenses held by them which will be retained by BIS and refunded only at the time of expiry/cancellation of licence.
4. BIS can draw the samples from open market, organized buyers, dispatch points etc. For foreign manufactures, where Authorized Indian Representative/ Importer is not the end consumer, the manufacturer shall submit details of their distribution channel(s) including warehouse, wholesalers, retailers etc. where the product will be available.
5. Once the surveillance process is complete and the test report is passing, Registration Department shall notify through the portal to the licensee/Authorized Indian Representative to collect the sample from the concerned laboratory to which the sample was sent for testing. In case the samples are not collected by the licensee/Authorized Indian Representative, laboratories can dispose off the samples as per the disposal policy under the Laboratory Recognition Scheme (LRS) of BIS. Once the test reports are received and are found non complying with the applicable Standard(s), BIS shall notify the licensee/Authorized Indian Representative and actions shall be initiated in accordance with guidelines to deal with non-conformity(s) of surveillance sample(s).
Should you have any question, please feel free to contact us:
Email: service@mrt-cert.com